Wang, Lei
Kuo, Hsiou-Ting
Zhang, Zhengxing
Zhang, Chengcheng
Chen, Chao-Cheng
Chapple, Devon
Wilson, Ryan
Colpo, Nadine
François Bénard,
Lin, Kuo-Shyan http://orcid.org/0000-0002-0739-0780
Funding for this research was provided by:
Canadian Institutes of Health Research (PJT-162243, PJT-180300, PJT-183956)
Article History
Received: 7 December 2023
Accepted: 25 January 2024
First Online: 2 February 2024
Declarations
:
: Not applicable.
: Not applicable.
: The compounds disclosed in this report are covered by a recent patent application (PCT/CA2023/050401), which has been licensed to Alpha-9 Theranostics Inc. François Bénard and Kuo-Shyan Lin are co-founders, consultants and shareholders of this company. Hsiou-Ting Kuo, Zhengxing Zhang and Chengcheng Zhang are also shareholders. Hsiou-Ting Kuo is a part-time employee of Alpha-9. Kuo-Shyan Lin, François Bénard, Lei Wang, Zhengxing Zhang and Chengcheng Zhang are also entitled to potential royalties upon commercialization of patented compounds.